Ftse Mib
33.857,47
0,36%
DAX
17.980,44
0,42%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
58.879,02
-0,41%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Akero Therapeutics Inc (AKRO) Akero Therapeutics Inc (AKRO) Notizie

Akero Therapeutics Inc

AKRO
19,71
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:48:57
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/4/202414:00GLOBEAkero Therapeutics Appoints Scott Gangloff as Chief..
08/3/202422:02GLOBEAkero Therapeutics Announces Closing of Public Offering of..
07/3/202422:01GLOBEAkero Therapeutics Announces Publication of Phase 2b..
07/3/202402:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202402:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:25EDGAR2Form 8-K - Current report
06/3/202423:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/3/202403:13GLOBEAkero Therapeutics Announces Pricing of Public Offering of..
05/3/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202412:05IHMARKETNEWSAMD Hits Regulatory Roadblock, GitLab’s Stock Tumbles on..
04/3/202423:34EDGAR2Form 144 - Report of proposed sale of securities
04/3/202423:30EDGAR2Form 144 - Report of proposed sale of securities
04/3/202423:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/3/202422:21GLOBEAkero Therapeutics Announces Proposed Public Offering of..
04/3/202413:55EDGAR2Form 8-K - Current report
04/3/202412:00GLOBEAkero Therapeutics Reports Statistically Significant..
29/2/202422:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202414:00GLOBEAkero Therapeutics to Present Topline Week 96 Results from..
29/2/202413:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202413:15EDGAR2Form 8-K - Current report
29/2/202413:00GLOBEAkero Therapeutics Reports Fourth Quarter and Full Year 2023..
14/2/202403:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202414:15GLOBEAkero Therapeutics to Present at the 42nd Annual J.P. Morgan..
30/12/202302:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202300:07EDGAR2Form 144 - Report of proposed sale of securities
19/12/202302:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202302:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202302:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202302:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202313:08EDGAR2Form 8-K - Current report
18/12/202313:00GLOBEAkero Therapeutics Announces First Patients Dosed in..
12/12/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202303:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202302:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202314:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202313:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:15EDGAR2Form 8-K - Current report
13/11/202313:00GLOBEAkero Therapeutics Reports Third Quarter 2023 Financial..
10/11/202314:57GLOBEAkero Therapeutics to Present Late-Breaking Oral and Poster..
08/11/202313:00GLOBEAkero Therapeutics to Present at Upcoming Healthcare..
17/10/202322:05GLOBEAkero Therapeutics to Present at the H.C. Wainwright 7th..
10/10/202314:04EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 19,71

La tua Cronologia

NASDAQ
AKRO
Akero Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network